1. Introduction {#s0005}
===============

Propionic acid is a three-carbon compound with a broad range of applications in the food, pharmaceutical and chemical industries. In addition to its use as an intermediate for the synthesis of cellulose fibres, herbicides, perfumes and pharmaceuticals, propionic acid is a strong antimicrobial agent used in animal feed and as a food preservative ([@bib13]). Propionic acid is mainly produced by petrochemical processes. However, the demand for green chemicals has renewed attention to fermenting propionibacteria for propionic acid production. Propionibacteria are gram-positive, rod-shaped, facultative anaerobes. Dairy propionibacteria are important industrial GRAS (generally recognized as safe) strains used in the food and cheese industry ([@bib26]). Propionibacteria have long been employed as starter and ripening cultures, responsible for flavour development and participating in the formation of cheese eyes ([@bib7], [@bib41]). Dairy strains are also used industrially to produce trehalose and vitamin B12 ([@bib20], [@bib35]).

The bioprocess for propionate production still suffers from low productivity, low yield, and expensive downstream purification costs; acetic and succinic acids are produced alongside propionic acid making the downstream separation costly ([@bib23], [@bib33]). Metabolic engineering strategies aiming to reduce by-products are thus needed. Improved yields can theoretically be achieved by deleting by-product genes, but metabolic manipulation of propionibacteria has developed slowly, and only a few examples exist in the literature engineering the best propionic acid producer, *P. acidipropionici.* Metabolic engineering strategies have focussed on enhancing flux through the Wood-Werkman cycle, either by directing carbon into the cycle through over-expression of pyruvate and phosphoenolpyruvate carboxylases or the pyruvate:methylmalonyl-CoA carboxyltransferase ([@bib2], [@bib22], [@bib43]). Other strategies that have been tested include the over-expression of components of the Wood-Werkman cycle itself ([@bib24], [@bib42]) or the targeting of acid tolerance associated processes such as trehalose synthesis ([@bib15]) and the glutamate decarboxylase or arginine deiminase pathways ([@bib12]). While *P. acidipropionici* remains resistant to engineering, unique metabolic features of this species were over-expressed in lower producers ([@bib43]). Few studies have targeted by-product production, and these have ultimately had limited success ([@bib22], [@bib40]). Ultimately, the limited phenotypic improvements in current studies and limitations in genetic engineering tools necessitate a genome-scale model to further aid design ([@bib43]).

Here, we utilise a recently developed genome-scale model for *P. freudenreichii* subsp*. shermanii* and the pan-*Propionibacterium* GEM to design genetic modification strategies. Because the production of propionic acid is already growth-coupled, classic growth-coupling strain design algorithms such as OptKnock ([@bib8]) favour sub-optimal strategies that limit energy generation, leaving cells more susceptible to acid stress. Given the depletion of the pH gradient is regarded as a major mechanism by which weak acids exert their toxicity on cells, we explored strategies favouring propionate production while maintaining high levels of energy generation or even exceeding those of wild-type strains. Strategies probed pathways consistent with the maximum production of energy and propionate in the native metabolism. By simultaneously trying to improve both energy output and propionate production, strains are expected to be readily evolvable to a higher producing phenotype while also improving acid tolerance. Such approaches facilitate the production of high producing mutants with minimum genetic perturbations; a requirement enforced by the few genetic modification tools available. Given the limited success of reducing acetate production in previous studies ([@bib22], [@bib40]), we over-expressed the PPP to test *in silico* simulation predictions and show that such a strategy results in lower acetate production without sacrificing growth. We then tested an alternative strategy consisting of over-expressing an ATP-PEPCK and MMD to enhance energy available to the cell and analyse how this affects the phenotype. We observed an extended exponential growth phase in the mutant strain. Because this strategy was reliant on the addition of CO~2~, the influence of CO~2~ on the *Propionibacterium* fermentation was also assessed, revealing undescribed biomass and propionate stimulating effects in propionibacteria.

2. Materials and methods {#s0010}
========================

2.1. Model preparation {#s0015}
----------------------

Simulations using the pan-*Propionibacterium* and *P. freudenreichii* subsp*. shermanii* models (manuscript in preparation) were performed in MATLAB using the COBRA toolbox ([@bib14]). The original excel models were first converted to SBML format and boundary metabolite exchanges were added to allow accumulation using an in-house tool, as previously described ([@bib31]). Glucose was allowed to be consumed as a carbon source at a rate of 1 mmol/gDW/h, while all other carbon-containing exchange metabolites were set to production only. No external terminal electron acceptors were available, including oxygen, sulphate and nitrate. Ammonium, phosphate, water and hydrogen sulphide fluxes were unconstrained. When required, additional reactions were added from the modelSEED database ([@bib28]). Reactions referenced herein have been matched to their unique modelSEED reaction identifiers or by the identifiers given within the original model ([Supplementary material Table S1](#s0135){ref-type="sec"}).

2.2. Identification of pathways of interest {#s0020}
-------------------------------------------

Pathways enabling maximum theoretical yield of propionate were hierarchically screened with respect to ATP yield in *P. freudenreichii* subsp*. shermanii*. This was performed by changing the objective function to maximise for the propionate boundary exchange reaction with a small weighting for the ATP drain reaction. Subsequent minimisation of total flux was utilised to assist in the identification of pathways that maximise yield. A key reaction in the pathway was then constrained to carry no flux so that alternative pathways could be determined. The procedure was repeated until the maintenance fell below 75% of the wild-type value. The same analysis was also performed on the pan-model. Pathways that could increase propionate production while maintaining a constant maximum energy yield were similarly calculated by maximising for the ATP drain reaction with a small bias for the propionate exchange flux. OptKnock simulations were implemented through the COBRA toolbox ([@bib8]).

2.3. Pathway yield calculation {#s0025}
------------------------------

Pathway yields were calculated by allowing free flux through central carbon metabolism. Flux through pathways that were identified to enhance propionate production were constrained as appropriate for the relevant scenario by constraining key enzymatic steps. These included citramalate synthase for the citramalate pathway, citrate synthase for the TCA cycle, and formate-tetrahydrofolate ligase for the glycine cleavage pathway. For each strategy, the expected yield of propionate with energy optimisation was calculated by maximising and minimising the propionate yield after maximising for the ATP yield. Additionally, the maximum energy yield associated with maximum propionate production was calculated by maximising the ATP yield with propionate constrained at the maximum theoretical yield of 1.714 moles/mole glucose. In all strategies, the methylmalonyl-CoA carboxyltransferase was set to irreversible (lower bound 0) to prevent infinite energy cycling when the sodium-pumping MMD was added. The relevant constraints for each strategy are detailed as follows: 1. GAPDH replacement of PGK and *Bifidobacterium* shunt knockout (constrained to 0 flux: phosphoglycerate kinase, phosphoketolase; added to model: GAPDH); 2. Acetate knock-out (constrained to 0 flux: citrate synthase, acetate kinase, cystathionine gamma-synthase, formate-tetrahydrofolate ligase); 3. PPP over-expression (constrained to 0 flux: citrate synthase, citramalate synthase, formate-tetrahydrofolate ligase); 4. Citramalate pathway over-expression (constrained to 0 flux: citrate synthase); 5. TCA cycle over-expression (constrained to 0 flux: citramalate synthase); 6. Glycine cleavage pathway over-expression (added to model: formate dehydrogenase); 7. Linear propionate pathway (added to model: PEPCK, MMD); 8. Combination of strategies 6 and 7 (added to model: formate dehydrogenase, PEPCK, MMD).

2.4. Bacterial strains and growth conditions {#s0030}
--------------------------------------------

*E. coli* DH5α was grown aerobically in Luria-Bertani medium at 37 °C and supplemented with 50 μg/mL apramycin (Am), 100 μg/mL ampicillin (Ap) or 50 μg/mL kanamycin (Km) when needed. *Propionibacterium* strains were grown anaerobically at 32 °C on complex medium containing yeast extract 10 g/L, trypticase soy broth 5 g/L, K~2~HPO~4~ 0.25 g/L, MnSO~4~ 0.05 g/L and glucose 80 g/L to mimic industrial-scale process conditions. Medium components and the carbon source were sterilized separately for 20 min at 121 °C. Sodium lactate broth (NBL) medium containing 10 g/L yeast extract, 10 g/L trypticase soy broth, and sodium lactate 10 g/L ([@bib18]), were used for the preparation of propionibacteria electrocompetent cells. When needed, media was supplemented with 50 μg/mL of erythromycin (Ery). *Propionibacterium* strains were kept at −80 °C using glycerol (20%) as cryoprotector. Strains and plasmids used in this study are listed in [Table 1](#t0005){ref-type="table"}.Table 1Bacterial strains, plasmids and primers used in this study.Table 1**Strain, plasmid or primerDescriptionReferenceStrains***P. acidipropionici*ATCC 4875ATCC*P. freudenreichii* subsp*. shermanii*ATCC 9614ATCCPf-ZOPATCC 9614 carrying plasmid pPACV76This studyPf-EMPATCC 9614 carrying plasmid pPACV70This studyPf-PAMATCC 9614 carrying plasmid pPACV86This study*E. coli* DH5αE. coli K12 F^-^*lacU169 (*φ*80lacZ∆M15) endA1 recA1 hsdR17 deoR supE44λ thi-1 gyrA96 relA1*Life Technologies**Plasmids**pRGO1Native plasmid *P. acidipropionici* ATCC 4875([@bib17])pGEM-TCloning vector, Ap^R^PromegapCR-Blunt II-TOPOCloning vector, Km^R^InvitrogenpSET152Cloning vector for conjugal transfer *E. coli-Streptomyces*, Am^R^([@bib5])pPACV16pGEM-T derivative carrying *orf1*, *orf2*, *orf5* and *orf6* from pRGO1This studypPACV29pPACV16 derivative carrying origin for intergeneric transfer and *aac(3)IV* gene from pSET152, Am^R^This studypBluescript II SK (+)Cloning vector, Ap^R^StrategenepPACV50pPACV29 derivative carrying multiple cloning sites and lacZ alpha fragment from pACYC, Am^R^This studypPACV70pPACV50 derivative carrying *ermE* gene from *S. erytharea,* Ery^R^This studypPACV76pPACV70 derivative carrying *zwf*, *opcA,* and *pgl* genes from *P. acidipropionici* ATCC 4875, Ery^R^This studypTOPO-MMDpCR-Blunt II-TOPO derivative carrying *mmd* genes from *P. acidipropionici* ATCC 4875, Km^R^.This studypPACV81pPACV70 derivative carrying *pckA* gene from *E. coli,* Ery^R^This studypPACV86pPACV81 derivative carrying *mmd* genes from *P. acidipropionici* ATCC 4875, Ery^R^This study**Primers**pRGO1_FACACCGTGATGCGCCCATGTpRGO1_RCTCTACTGCTAGCCATCAGTpSET152_FCTGTGCGCAGAGTTGGTAGCTCTTGATCCpSET152_RCTGTGCGCAGGATCTTTTCCGCTGCATAAMCS_FCTTATCGTTTAAACGCAGTGAGCGCAACGCAATTMCS_RGGCGCTGTTTAAACCTAGTCCCATTCGCCATTCAGGCermE_FTTTTCTAGACTACCGCTGCCCGGGTCCermE_RGTGCAGGTACCAGCCCGACZOP_FTTTCATATGCTCGACACAGGTTCCGCZOP_RTTTTCTAGATCACAGCACGCAGTTGTACCPermE_FTTTTCTAGAGGTTCGACTGGCACCGGCACCGCGCPermE_RTTTCATATGCGCTGGATCCTACCAACCGGpckA_FTTTAAGCTTCATATGCGCGTTAACAATGGpckA_RTTTTCTAGAGGTACCTTACAGTTTCGGACCAGCCGPermE_F1TTTAAGCTTGGTACCGGTTCGACTGGCACCGGCACCGCGCPermE_R1TTTTCATATGCGCTGGATCCTACCAACCGGPAM_FTTTTGGTACCCATATGCAGGCCGACGGCAGGACPAM_RTTTTTCTAGATTATAACTAGAAACTCCCCATCAGGGPF_FCTTCACCCGGGCCATCPF_RCCGAGCACGATCCGATG

2.5. Genomic DNA and plasmid extraction {#s0035}
---------------------------------------

Genomic DNA of *P. freudenreichii* subsp*. shermanii*, *P. acidipropionici* and *Saccharopolyspora erythraea* were extracted using Invitrogen PureLink Genomic DNA kit. Plasmid extraction was performed using QIAgen MiniPrep plasmid purification kit. For plasmid extraction from propionibacteria, 5 mL of overnight culture was centrifuged and resuspended in 250 μL of buffer P1 containing 100 μg/mL RNAse and 20 mg/mL of lysozyme (Sigma-Aldrich). Cells were incubated at 37 °C for 30 min and extraction was continued as specified in the plasmid purification kit protocol.

2.6. Construction of expression vector {#s0040}
--------------------------------------

pRGO1 plasmid extracted from *P. acidipropionici* ATCC 4875 was used as a template for amplification of a PCR fragment containing regions *orf1*, *orf2*, *orf5* and *orf6* ([@bib17]), using primers pRGO1_F and pRGO1_R ([Table 1](#t0005){ref-type="table"}). The resulting PCR fragment was cloned into pGEM-T vector obtaining plasmid pPACV16. Plasmid pSET152 was used as a template for amplification of a PCR fragment containing the apramycin resistance gene, *aac(3)IV*, and the origin of intergeneric transfer ([@bib5]). Primers pSET152_F and pSET152_R containing FspI restriction sites were used for amplification ([Table 1](#t0005){ref-type="table"}). The resulting fragment was digested with FspI and subsequently ligated to DraI/SspI digested plasmid pPACV16, obtaining plasmid pPACV29. The multiple cloning site and lacZ alpha fragments were amplified from pBluescript II SK (+) using primers MCS_F and MCS_R with PmeI sites ([Table 1](#t0005){ref-type="table"}) and cloned into NheI/Klenow treated plasmid pPACV29 obtaining plasmid pPACV50. The erythromycin resistance gene, *ermE*, was amplified from *Saccharopolyspora erythraea* genomic DNA using primers ermE_F and ermE_R with KpnI and XbaI sites, respectively ([Table 1](#t0005){ref-type="table"}). *ermE* was cloned into digested KpnI/XbaI pPACV50, obtaining plasmid pPACV70. *zwf*, glucose-6-phosphate 1-dehydrogenase (PACID_22670), *opcA,* putative allosteric activator of Zwf (PACID_22680) and *pgl*, 6-phosphogluconolactonase (PACID_22690), genes were amplified as a single fragment using *P. acidipropionici* ATCC 4875 genomic DNA as a template and primers ZOP_F and ZOP_R with NdeI and XbaI sites, respectively ([Table 1](#t0005){ref-type="table"}). *ermE* promoter (PermE) was amplified using *S. erythraea* genomic DNA as a template and primers PermE_F and PermE_R with XbaI and NdeI sites, respectively ([Table 1](#t0005){ref-type="table"}). PACID_22670, PACID_22680 and PACID_22690 and PermE PCR fragments were digested with XbaI/NdeI and ligated to XbaI digested plasmid pPACV70 obtaining plasmid pPACV76.

*pckA* gene coding for PEPCK from *E. coli* was amplified from *E. coli* DH5α genomic DNA as template and primers pckA_F and pckA_R with NdeI and KpnI sites. PermE was amplified using *S. erythraea* genomic DNA as a template and primers PermE_F1 and PermE_R1 with KpnI and NdeI sites, respectively ([Table 1](#t0005){ref-type="table"}). PEPCK and PermE PCR fragments were digested with KpnI/NdeI and ligated to KpnI digested plasmid pPACV70 obtaining plasmid pPACV81.

PACID_02160, PACID_02170, PACID_02180 and PACID_02190 genes for MMD were amplified as a single fragment using *P. acidipropionici* ATCC 4875 genomic DNA as a template and primers PAM_F and PAM_R with NdeI and XbaI sites, respectively ([Table 1](#t0005){ref-type="table"}). MMD and PermE, amplified with primers PermE_F and PermE_R, PCR fragments were digested with NdeI/XbaI and ligated to XbaI digested plasmid pCR-Blunt II-TOPO obtaining plasmid pTOPO-MMD. pTOPO-MMD XbaI fragment was posteriorly cloned into XbaI digested pPACV81 obtaining pPACV86.

2.7. Transformation protocol {#s0045}
----------------------------

Transformation of *P. freudenreichii* subsp. *shermanii* was performed by electroporation as described in previous studies ([@bib3], [@bib17]). Briefly, cells were grown in NBL medium until OD 0.5--1, cooled on ice for 15 min, and centrifuged at 5000 rpm at 4 °C. Cells were then washed four times with cold glycerol 10% and resuspended in electroporation buffer (1/50 of the original volume). 90 μL of resuspended cells were mixed with 1--2 μg of plasmid DNA in a 0.1 cm cuvette and incubated on ice for 10 min. Electroporation was performed using a MicroPulser Electroporator (Biorad Laboratories, Richmond, CA, USA) at 20 kV/cm and time constants between 4.5 and 5.0 ms. After an electroporation pulse, 1 mL of recovery NBL medium was added and cells were incubated for 3 h at 32 °C. Cells were posteriorly plated on NBL agar supplemented with 50 μg/mL of erythromycin. Colonies appeared on plates after 10--15 days of incubation. Transformants were confirmed by plasmid extraction and restriction profiles. To confirm that the positive transformants were *P. freudenreichii* subsp. *shermanii* strains, genomic DNA was extracted and PCR amplification was performed using oligos PF_F and PF_R ([Table 1](#t0005){ref-type="table"}). To confirm segregational stability of plasmids, *P. freudenreichii* subsp*. shermanii* transformants were grown for 25 generations without any addition of antibiotics and plated on solid medium with and without erythromycin. No differences were observed between number of colonies in each plate, indicating the plasmids were segregationally stable. Structural stability was also studied by cultivation in selective medium for 25 generations and subsequent plasmid extraction. No changes in the restriction profile were observed, indicating that the plasmids were structurally stable.

2.8. Fermentation conditions {#s0050}
----------------------------

Glycerol stock cultures were revived in 1.5 mL Eppendorf tubes containing 1 mL of complex media inoculated with 0.8% (v/v) of the glycerol stock and grown for 24 h at 32 °C. The culture was transferred to a 15 mL Falcon tube containing 14 mL of complex media and grown for an additional 24 h. 5% (v/v) of this culture was used to inoculate 250 mL serum bottles containing 100 mL of complex media and grown for an additional 24 h. Cells from the serum bottles in mid-exponential phase were used to inoculate the fermenter at an initial OD600nm of 0.3. The Pf-ZOP and Pf-EMP fermentation were performed using a 1 L BIOSTAT® A fermenter ([@bib25]). The fermenter was equipped with standard probes and controllers, controlling pH, dissolved oxygen, temperature, and agitation. The agitation rate was kept constant at 300 rpm and pH was controlled at 6.4 using 10 M NaOH. The temperature of the culture was maintained at 32 °C using an electric jacket and a recirculation chiller. The exhaust gas condenser was set to 20% to avoid medium evaporation. Prior to inoculation, the fermenter was sparged with N~2~ for at least 15 min. A constant N~2~ flow was kept for the entire fermentation at a flow rate of 300 sccm.

Fermentations for strain Pf-PAM and CO~2~-sparged Pf-EMP were performed in Multifors Infors HT 1 L bioreactors with an operation volume of 0.9 L. The fermenters were equipped with standard probes and controllers, controlling pH, dissolved oxygen, temperature, and agitation. The agitation rate was kept constant at 300 rpm and pH was controlled at 6.4 using 10 M NaOH. The temperature of the culture was maintained at 32 °C. The fermenter was initially sparged with a gas mix Ar (80%) and CO~2~ (20%) for at least 15 min. A constant gas mix Ar (80%) and CO~2~ (20%) flow was kept for the entire fermentation at 0.3 VVM (270 sccm). All fermentations were performed in duplicates.

2.9. Analytical methods {#s0055}
-----------------------

The optical density of the culture was measured at 600 nm using a Biochrom Libra S12 UV/Vis. Organic acids and carbohydrates were quantified by ion-exclusion chromatography using an Agilent 1200 HPLC system and an Agilent Hiplex H column (300 × 7.7 mm, PL1170-6830) with a guard column (SecurityGuard Carbo-H, Phenomenex PN: AJO-4490). Sugars and alcohols were monitored using a refractive index detector (Agilent RID, G1362A), set on positive polarity and optical unit temperature of 40^o^C. Organic acids were monitored at 210 nm (Agilent MWD, G1365B). 30 μL of the sample was injected onto the column using an autosampler (Agilent HiP-ALS, G1367B), and column temperature kept at 40 °C using a thermostatted column compartment (Agilent TCC, G1316A). Analytes were eluted isocratically with 4 mM H~2~SO~4~ at 0.4 mL/min for 50 min. Chromatograms were integrated using the software ChemStation.

3. Results {#s0060}
==========

3.1. Strain design algorithms {#s0065}
-----------------------------

Initial genetic engineering targets were designed using the OptKnock algorithm. Three key strategies were identified to improve flux towards propionate. The first strategy involved reducing the total energy available to the organism by knocking out the energy yielding steps of glycolysis. Knocking-out phosphoglycerate kinase (*pgk*) forced the cells to increase organic acid production relative to growth. This can be compensated by the introduction of the NADPH-dependent glyceraldehyde-3-phospate dehydrogenase (*gapdh)*. The final two strategies directly targeted acetate production. The first was the simplistic knockout of acetate, achieved in *P. freudenreichii* subsp. *shermanii* by targeting the acetate kinase. The second strategy targeted the redox balance instead to favour propionate production and inhibit acetate production by targeting glucose-6-phosphate isomerase (*pgi*), forcing flux through the PPP and generating an excess of reduced cofactors. This strategy is superseded by the over-expression of the PPP which can be tailored to maximise for energy production ([Fig. 1](#f0005){ref-type="fig"}) and is not commented on further. The knockout strategies result in lower energy yields and are therefore less favourable ([Table 2](#t0010){ref-type="table"}).Fig. 1Phase plane analysis for glucose catabolism by *P. freudenreichii* subsp. *shermanii* demonstrating the influence of the propionate yield and PPP expression on the ATP yield with an objective of ATP maximisation. Phosphoglycerate kinase knockout strategy (pgk KO), acetate knockout strategy (acetate KO), TCA or citramalate pathway over-expression strategy (TCA/Cit OE), glycine cleavage based pathway over-expression (Gly cleavage pathway), linear propionic acid pathway strategy (Linear PA pathway) and the combined strategy (Linear PA + Gly cleavage), have been mapped on for comparison. Each point represents optimal over-expression of the given pathway for propionate or energy production or the expected metabolism after knock-out.Fig. 1Table 2Simulated flux distributions under energy maximisation and propionate maximisation with availability of the associated metabolic engineering strategies.Table 2**StrategyATP maximisation**[a](#tbl2fna){ref-type="table-fn"}**PA maximisation**[b](#tbl2fnb){ref-type="table-fn"}**ATPPA maxPA minATPWild-type***l*~1~-norm solution using central carbon metabolism4.001.331.333.43[c](#tbl2fnc){ref-type="table-fn"}**Knock-out**Energy yielding step of glycolysis (PGK)2.001.331.331.71Acetate kinase (ACK)3.431.711.713.43[c](#tbl2fnc){ref-type="table-fn"}**Over-expression**Pentose phosphate pathway4.001.331.333.43TCA/citramalate pathways4.001.331.333.71Glycine cleavage system pathway4.001.61.333.43Glycine cleavage system pathway with formate dehydrogenase4.001.711.334.00Linearised PA pathway4.331.331.333.86Glycine cleavage and linear PA pathways4.431.711.714.43[^3][^4][^5]

3.2. Native *P. freudenreichii* subsp. *shermanii* pathways associated with improved propionic acid yields {#s0070}
----------------------------------------------------------------------------------------------------------

The native metabolism of propionate biosynthesis in *P. freudenreichii* subsp. *shermanii* was explored using two approaches. Guided by the knowledge that the maximal theoretical yield of propionate is redox limited, we first identified pathways that were capable of achieving the maximum theoretical yield of propionate production. The second objective was to maximise ATP generation. This gave a series of over-expression targets that generate additional reduced cofactors that can shift metabolism towards propionate production under minimal energetic cost. We then studied pathways that could improve propionate production without energy penalty. In all cases, fluxes were redistributed through pathways that produced more reduced cofactors and therefore allowed an increase in propionate titre.

Modelling suggested that at the maximum theoretical yield of propionate production of 1.7 mol/mol glucose, 3.7 mol ATP/glucose can be achieved. This is more than 90% of the maximum energy yield of the native strain (which can achieve 4 ATP/glucose), suggesting that the homofermentative production of propionate suffers only a relatively minor energetic disadvantage. Two pathways were identified that could achieve the maximum propionate yield with this energy yield: the citramalate pathway, which synthesises 2-oxobutyrate from pyruvate and acetyl-CoA that can be further degraded to propionate with a corresponding gain in ATP, and the oxidative branch of the tricarboxylic acid (TCA) cycle ([Fig. 2](#f0010){ref-type="fig"}). One final pathway was identified as a potential candidate, the PPP. This pathway suffers a minor energetic penalty compared to the previously mentioned pathways with a yield of 3.4 ATP/glucose at the maximum theoretical yield of propionate ([Table 2](#t0010){ref-type="table"}). The expected propionate and energy yields from this pathway are demonstrated in [Fig. 1](#f0005){ref-type="fig"} at varying levels of expression, with an optimum flux of 86% of the glucose uptake rate to maximise for both energy and propionate.Fig. 2Central carbon metabolism and relevant metabolic pathways of *P. freudenreichii* subsp. *shermanii* discussed in this work. Pathways are colour-coded. Upregulation of the glycine cleavage pathway, TCA cycle (via the alpha-ketoglutarate dehydrogenase), the citramalate pathway or the PPP are all possible ways to source additional reduced cofactors for propionate generation, although the ATP generation through the glycine cleavage pathway makes this particularly attractive. Potential knock-out strategies target glycolysis or the acetate synthesis pathway. Non-native enzymes proposed in this work are depicted in black.Fig. 2

The production of propionate and acetate in a 2:1 ratio (4/3 mol propionate/glucose) is expected to correspond to the maximisation of energy for *P. freudenreichii* subsp*. shermanii* under the *l*~1~-norm flux distribution, which assumes minimisation of total metabolic fluxes. Exploring the maximum range of propionate production while still producing 4 ATP/glucose reveals that propionate can also be produced with formate as an oxidised species rather than acetate. The pathway utilises the synthesis and subsequent degradation of serine via the glycine cleavage system to produce 10-formyltetrahydrofolate, which is then used to regenerate tetrahydrofolate while phosphorylating ADP. This pathway will be referred to hereafter as the glycine cleavage pathway ([Fig. 2](#f0010){ref-type="fig"}). The combination of this pathway with glycolysis and the Wood-Werkman cycle enables the production of 1.6 mol propionate/mol glucose and 0.8 moles of formate. Given that formate is another acid it will contribute to both acid stress and process separation costs. Removal is possible by over-expressing a non-native formate dehydrogenase or formate hydrogenlyase. Depending on the conversion efficiency of formate to carbon dioxide, the combination of the glycine cleavage pathway and formate dehydrogenase can achieve a yield of 1.6--1.7 mol propionate/mol glucose, consistent with the maximum theoretical yield, at the highest native energy yield possible of 4 ATP/glucose ([Table 2](#t0010){ref-type="table"}).

3.3. Pan-genome guided design {#s0075}
-----------------------------

We probed the diversity of the pan-genome of propionibacteria to look for energetically efficient pathways for propionate production. Most notably, we found *P. acidipropionici* species contained a sodium-pumping MMD, while *P. propionicum* contained a PEPCK that uses GTP as a cofactor rather than the typical pyrophosphate-dependent PEPCK of *Propionibacterium*. The combination of these two enzymes form an alternative linear pathway to the Wood-Werkman cycle for the degradation of PEP to propionate, yielding more energy than the Wood-Werkman cycle itself. According to our model, 4.33 ATP/glucose is expected ([Table 2](#t0010){ref-type="table"}). This scenario does not necessarily alter the ratio of propionate to acetate ([Table 2](#t0010){ref-type="table"}), unless flux through the glycine cleavage system pathway is possible, which may be driven by evolution as this favours generation of ATP.

3.4. Coupling the maximum energy yield with the utmost theoretical yield of propionate {#s0080}
--------------------------------------------------------------------------------------

Our results suggest the maximum theoretical yield of propionate can be achieved while achieving the maximum energy yield from glucose through the glycine cleavage system pathway and expression of the formate dehydrogenase. Given that this pathway does not incur an energetic disadvantage to supply reduced cofactors this offers a valuable strategy to increase propionate yield. The introduction of the alternative linear pathway for propionate is advantageous for cells as it enhances the amount of energy that can be achieved through the production of propionate and therefore actively selects for its production, so long as the supply of reduced cofactors does not incur an extra energetic cost. The combination of both strategies marginally improves the maximum energy yield from the fermentation when propionate is the sole product; thus coupling the maximum theoretical yield of propionate to the maximum energy yield while simultaneously improving the maximum energy yield relative to the wild-type strain. Presuming flux through the glycine cleavage based pathway can be coupled to ATP regeneration then a yield of 4.43 ATP/glucose could be achieved with the production of 1.7 moles propionate/mol glucose, which is clearly superior to the other proposed strategies ([Fig. 1](#f0005){ref-type="fig"}).

3.5. Construction of expression vectors and transformation of propionibacteria {#s0085}
------------------------------------------------------------------------------

Over-expression of the PPP was selected as a lead strategy for testing the hypothesis that increasing the availability of reduced cofactors would reduce by-products in propionibacteria. Thus, genes *zwf*, *opcA* and *pgl,* were amplified from *P. acidipropionici* ATCC 4875 genomic DNA and cloned into pPACV70 under PermE promoter for gene expression, resulting in plasmid pPACV76 ([Fig. 3](#f0015){ref-type="fig"}). To improve energy yield from propionate production, a linear pathway for propionate production for *P. freudenreichii* subsp*. shermanii* was designed which used the non-native ATP-PEPCK and MMD as well as native components of the Wood-Werkman cycle. To test this pathway, the ATP-PEPCK and MMD were overexpressed.Fig. 3Plasmid maps of pPACV70, pPACV76 and pPACV86. Open reading frames orf1, orf2, orf5 and orf6 from pRGO1 are indicated in burgundy arrows in pPACV70, pPACV76 and pPACV86 maps. *zwf*, *opcA* and *pgl* genes are indicated by blue arrows in pPACV76 map. *pckA* and *mmd* genes are indicated by blue arrows in pPACV86 map.Fig. 3

*pckA* and *mmd* genes were amplified from *E. coli* and *P. acidipropionici* ATCC 4875 genomic DNA, respectively, and cloned into pPACV70 under the control of PermE for expression, resulting in plasmid pPACV86 ([Fig. 3](#f0015){ref-type="fig"}).

Plasmids pPACV76, pPACV86 and empty plasmid pACV70 were transformed into *P. freudenreichii* subsp*. shermanii* by electroporation obtaining Pf-ZOP, Pf-PAM and Pf-EMP strains, respectively. Plasmid extraction and restriction profile confirmed the presence of each plasmid. Pf-ZOP, Pf-PAM and Pf-EMP strains were confirmed to be *P. freudenreichii* subsp*. shermanii* by genomic DNA extraction and PCR amplification.

3.6. Effects of zwf, opcA and pgl overexpression on fermentation kinetics {#s0090}
-------------------------------------------------------------------------

Pf-ZOP and Pf-EMP strains were grown in complex medium with glucose as carbon source to study the effect of expression of *zwf*, *opcA* and *pgl* on cell growth and organic acids production ([Fig. 4](#f0020){ref-type="fig"}A, B and C). No difference in growth rates was observed between Pf-ZOP and Pf-EMP strains ([Fig. 4](#f0020){ref-type="fig"}A). Glucose consumption and propionate production remained similar between the two strains until the end of the exponential growth phase, at which point the rate of propionate production and glucose consumption was slightly higher in Pf-EMP. In contrast, the rate of acetate production was approximately 3.5 times lower in Pf-ZOP during the exponential growth phase. The ratio of propionate to acetate was improved 4-fold from 2.27 in Pf-EMP to 8.94 in Pf-ZOP ([Table 3](#t0015){ref-type="table"}). During the pseudo-stationary phase, growth occurred at a much reduced rate and acetate production in Pf-ZOP increased to a similar rate as Pf-EMP without a concomitant increase in propionate production ([Table 3](#t0015){ref-type="table"} and [Fig. 4](#f0020){ref-type="fig"}D).Fig. 4Kinetics of batch fermentation of glucose by Pf-EMP and Pf- ZOP strains. A) Cell growth. Production of propionate (PA), acetate (AA), succinate (SA) and glucose consumption (Gluc) in (B) Pf-EMP and (C) Pf-ZOP. D) Absolute PA/AA ratio (g/g). Fermentation of Pf-EMP and Pf-ZOP strains were performed in duplicate. Error bars correspond to the deviation of replicates from the mean.Fig. 4Table 3Fermentation kinetic parameters of Pf-EMP and Pf-ZOP during exponential and stationary growth phase.Table 3**Exponential phaseStationary phaseStrainPf-EMPPf-ZOPPf-EMPPf-ZOPGrowth rate (h**^**−1**^**)**µ0.077 ± 0.0040.077 ± 0.0040.006 ± 0.0010.008 ± 0.000**Rates (g/gDW h)**Glucose consumption0.198 ± 0.0520.263 ± 0.0480.048 ± 0.0120.048 ± 0.002Propionate0.076 ± 0.0050.086 ± 0.0060.022 ± 0.0050.019 ± 0.001Acetate0.033 ± 0.0030.009 ± 0.0010.006 ± 0.0020.003 ± 0.000Succinate0.004 ± 0.0010.001 ± 0.0010.005 ± 0.0010.006 ± 0.001**Ratios (g/g)**PA/AA2.270 ± 0.1038.940 ± 0.4332.900 ± 0.8204.190 ± 0.360PA/Glc0.270 ± 0.0570.280 ± 0.0540.450 ± 0.0240.390 ± 0.027**Productivity (g/L h)**Glucose consumption0.520 ± 0.1400.600 ± 0.0970.400 ± 0.0950.370 ± 0.016Propionate0.200 ± 0.0220.190 ± 0.0160.180 ± 0.0420.150 ± 0.004Acetate0.083 ± 0.0120.020 ± 0.0020.040 ± 0.0240.034 ± 0.003Succinate0.009 ± 0.0020.005 ± 0.0020.045 ± 0.0070.044 ± 0.003[^6]

3.7. Effects of CO~2~ sparging and MMD and PEPCK overexpression on fermentation kinetics {#s0095}
----------------------------------------------------------------------------------------

Pf-PAM and Pf-EMP strains were grown in complex medium with glucose as carbon source and a 20% carbon dioxide sparge. A CO~2~ sparge was utilised because preliminary serum bottle trials suggested this was important to achieve a high activity of the PEPCK, observed via enhanced biomass formation (data unpublished). Growth rates remained similar, but the arrest of exponential growth was prolonged slightly in the Pf-PAM strain, resulting in an additional, short growth phase from 50 to 64 h which we will refer to as the transition phase ([Fig. 5](#f0025){ref-type="fig"}A). During this transition phase, glucose was rapidly catabolised to propionate and acetate, but the production of organic acids and consumption of sugar remained similar ([Fig. 5](#f0025){ref-type="fig"}B, C, [Table 5](#t0025){ref-type="table"}). The production of acetate relative to propionate was increased ([Fig. 5](#f0025){ref-type="fig"}D). At the end of this prolonged growth phase, Pf-PAM had achieved a 20% higher biomass than Pf-EMP ([Fig. 5](#f0025){ref-type="fig"}D). Throughout the exponential growth phase, glucose was more rapidly converted to propionate, acetate and succinate by Pf-PAM ([Table 4](#t0020){ref-type="table"}). The growth rate and productivities of both acetate and propionate were markedly higher in the transition phase ([Table 5](#t0025){ref-type="table"}) followed by the onset of the pseudo-stationary phase where growth in Pf-PAM was lower and acetate production double compared to Pf-EMP ([Table 4](#t0020){ref-type="table"}).Fig. 5Kinetics of batch fermentation of glucose by Pf-EMP and Pf- PAM strains with a CO~2~ sparge. A) Cell growth. Production of propionate (PA), acetate (AA), succinate (SA) and glucose consumption (Gluc) in (B) Pf-EMP and (C) Pf-ZOP. D) Absolute PA/AA ratio and gram dry weight ratio (GDW). Fermentation of Pf-EMP and Pf-PAM strains were performed in duplicate. Error bars correspond to the deviation of replicates from the mean and are depicted where replicate data is available.Fig. 5Table 4Fermentation kinetic parameters of Pf-EMP and Pf-PAM during exponential and stationary growth phase.Table 4**Exponential phaseStationary phaseStrainPf-EMPPf- PAMPf-EMPPf-PAMGrowth rate (h**^**−1**^**)**µ0.083 ± 0.0040.086 ± 0.0010.007 ± 0.0010.005 ± 0.000**Rates (g/gDW h)**Glucose consumption0.160 ± 0.0260.205 ± 0.0090.047 ± 0.0050.044 ± 0.004Propionate0.072 ± 0.0040.082 ± 0.0040.021 ± 0.0020.018 ± 0.002Acetate0.022 ± 0.0020.029 ± 0.0010.003 ± 0.0000.005 ± 0.001Succinate0.001 ± 0.0010.003 ± 0.0000.005 ± 0.0010.006 ± 0.001**Ratios (g/g)**PA/AA3.259 ± 0.3022.857 ± 0.1827.860 ± 1.5363.373 ± 0.529PA/Glc0.449 ± 0.0760.400 ± 0.0250.442 ± 0.060.416 ± 0.059**Productivity (g/L h)**Glucose consumption0.406 ± 0.0950.485 ± 0.0610.515 ± 0.0170.529 ± 0.008Propionate0.187 ± 0.0220.192 ± 0.0280.226 ± 0.0040.219 ± 0.007Acetate0.057 ± 0.0090.068 ± 0.0090.030 ± 0.0030.066 ± 0.003Succinate0.002 ± 0.0030.006 ± 0.0010.060 ± 0.0040.074 ± 0.003[^7]Table 5Fermentation kinetic parameters of Pf-EMP and Pf-PAM during transition phase.Table 5**Transition phaseStrainPf-EMPPf- PAMGrowth rate (h**^**−1**^**)**µ0.017 ± 0.0010.033 ± 0.003**Rates (g/gDW h)**Glucose consumption0.071 ± 0.0220.089 ± 0.008Propionate0.042 ± 0.0050.044 ± 0.004Acetate0.005 ± 0.0010.008 ± 0.001Succinate0.004 ± 0.0010.004 ± 0.000**Ratios (g/g)**PA/AA1.019 ± 3.6082.666 ± 3.229PA/Glc0.554 ± 0.1080.498 ± 0.019**Productivity (g/L h)**Glucose consumption0.522 ± 0.1540.699 ± 0.039Propionate0.306 ± 0.0280.349 ± 0.006Acetate0.040 ± 0.0030.063 ± 0.004Succinate0.030 ± 0.0040.028 ± 0.000[^8]

4. Discussion {#s0100}
=============

4.1. Feasibility of the proposed genetic engineering strategies {#s0105}
---------------------------------------------------------------

The biological production of propionic acid would be economically feasible if propionibacteria could be engineered to reach near maximum theoretical yields while maintaining high titre and volumetric productivity ([@bib33]). Current strategies in the literature have focussed on directly upregulating enzymatic components of the propionate production pathway ([@bib2], [@bib22], [@bib43]) or by improving acid tolerance by upregulating the arginine deiminase, glutamate decarboxylase amino acid systems, or trehalose synthesis ([@bib12], [@bib15]). These strategies compete with, rather than suppress, acetate production and have relatively minor improvements in phenotype, or represent a carbon drain and reduce the yield.

Metabolic modelling was therefore used to identify more effective strategies. The classic strain design algorithm, OptKnock ([@bib8]), was originally used which works on a principle of growth coupling the production of a target product by eliminating alternative, energetically superior pathways. Because propionate is already growth coupled, these strategies inherently either targeted the elimination of other by-products (such as an acetate kinase knockout) or energy generating steps (such as *pgk* knockout to prevent a net energy yield through glycolysis). Because the fermentation titre is ultimately limited by product inhibition ([@bib6]), primarily thought to be caused by the futile cycling of protons across the membrane, the availability of energy for proton extrusion should dictate acid stress tolerance. Therefore, reducing the energy yield risks trading titre off against fermentation yield and the most successful strategies will enhance propionate production while maintaining, or even improving, the high energy yield of *Propionibacterium*.

Here, we present a number of engineering strategies, which *in silico,* achieve higher yield ([Table 2](#t0010){ref-type="table"}). The strategies vary in complexity and the limited capacity to implement these strategies with molecular biology means the testing of any strategy is inherently difficult. A strong focus was therefore placed on ensuring these strategies are robust in their implementation. Each strategy proposed is analysed in detail in the supplementary material [Table S2](#s0135){ref-type="sec"}. While *P. freudenreichii* subsp. *shermanii* serves as a good propionibacteria model, the ultimate goal is to translate these strategies into strains most suited to industrial production, such as *P. acidipropionici*, where genetic engineering remains elusive. It is likely that future work needs to address the large variety of restriction modification (RM) systems which have been identified in *Propionibacterium*, compiled in the REBASE database ([@bib32]), before this is possible. In other non-model organisms, RM systems have been by-passed by the expression of native methylation components in the cloning host ([@bib27], [@bib46]).

In the current study, we explored two (PPP and linear PA) of the strategies identified ([Table 2](#t0010){ref-type="table"}) in the more readily engineered *P. freudenreichii* subsp. *shermanii*. The PGK strategy was excluded because it cripples energy production, while the ACK knockout strategy was excluded because *P. freudenreichii* subsp. *shermanii* utilises different pathways for acetate production to *P. acidipropionici* (manuscript in preparation). The TCA and citramalate pathways are energetically advantageous over the PPP but rely on the promiscuity of enzymes associated with acetate metabolism; thus, both pathways would require extensive protein engineering to change enzyme selectivity. Finally, the glycine cleavage pathway is particularly promising on its own or coupled to the linear pathway due to its ability to couple the regeneration of ATP to the production of reduced cofactors. However, it involves at least nine enzymes.

4.2. Influence of PPP over-expression on the metabolism of *P. freudenreichii* subsp. *shermanii* {#s0110}
-------------------------------------------------------------------------------------------------

A strategy to manipulate the redox metabolism of *Propionibacterium* using the PPP is presented. Over-expression of the PPP by upregulating the oxidative branch is a proven strategy ([@bib1]) and was performed here by upregulating the first two steps of the oxidative branch of the PPP. The PPP is a favourable engineering target given it is compatible with other engineering strategies already implemented such as upregulation of the Wood-Werkman cycle ([@bib24], [@bib42]) and is tractable within the limits of current engineering tools. The PPP has long been thought to be the primary pathway responsible for the increased ratio of propionate to acetate in higher producing propionibacteria ([@bib29]) but this has never been tested.

Consistent with the modelling, the strategy resulted in a 4-fold improvement in the propionate to acetate ratio and a 13% improvement in the rate of propionate production without increased production of succinate. Our findings demonstrate that over-expression of the PPP is a valid alternative to supplementing the media with glycerol without inhibiting growth, an initial concern of Wang and colleagues ([@bib43]). This is despite a reduced energy yield from the pathway; suggesting this is partially compensated for by either the increase in NADPH or activity of the PPP which has been shown to combat oxidative stress ([@bib21]). Importantly, these results show that NADPH can be coupled to the Wood-Werkman cycle, although the exact mechanism remains unclear, and supports the hypothesis that a higher flux through the PPP may be responsible for the divergence in the propionate to acetate ratio from 2 ([@bib29]).

In Pf-EMP, a molar ratio of propionate to acetate of \~2:1 was observed during exponential growth. This ratio is consistent with the simulated *l*~1~-norm flux distribution for the maximisation of energy. At such a ratio, it is expected that flux through the PPP is minimal. In comparison, Pf-ZOP achieved a molar propionate to acetate ratio of \~8. If all additional reduced cofactors required to achieve such a ratio are assumed to come from the PPP, the model predicts that the split ratio of flux between glycolysis and the PPP is approximately 2:3, implying 60% of the glucose uptake was directed towards the PPP. This compares to the 86% required in order to achieve the maximum theoretical yield.

Pf-ZOP appears to experience a partial release of the over-expression phenotype at the onset of the stationary phase. In particular, the propionate production rate reduces with respect to Pf-EMP ([Table 3](#t0015){ref-type="table"}), which ultimately reduces the propionate to acetate ratio from 9.2 (g/g) at the end of the exponential growth phase to 6 (g/g) at the end of the fermentation; although this is still a 55% improvement over Pf-EMP. Conversely, Pf-EMP showed an improvement in the ratio of propionate to acetate at the onset of stationary phase. We postulate this different behaviour may be due to the activity of the *Bifidobacterium* shunt recently identified in *P. freudenreichii* subsp. *shermanii* (manuscript in preparation). The *Bifidobacterium* shunt catabolises sugars via the PPP and a phosphoketolase enzyme to produce primarily acetate and lactate in *Bifidobacterium*, where it is over-expressed in response to stress ([@bib36]). Expression in response to cold stress ([@bib10]) and apparent activation at the onset of stationary phase suggests it may play a similar role in *P. freudenreichii* subsp. *shermanii*.

4.3. Influence of carbon dioxide sparging on the metabolism of *P. freudenreichii* subsp. *shermanii* {#s0115}
-----------------------------------------------------------------------------------------------------

Fermenters were sparged with CO~2~ to test the linear propionate pathway strategy. Sparging improved biomass production, which can be observed by comparisons of the strains harbouring the empty plasmid ([Fig. 6](#f0030){ref-type="fig"}). While biomass was similar at the end of the exponential growth phase, propionibacteria supplied with CO~2~ grew for longer, resulting in 25% higher biomass. The rate of acetate production across the exponential growth phase is reduced by one-third and halved in the stationary phase ([Table 3](#t0015){ref-type="table"}, [Table 4](#t0020){ref-type="table"}). This suggests CO~2~ addition somehow alters metabolism to produce more reduced cofactors and suppresses acetate production.Fig. 6Comparison of fermentations of Pf-EMP with a CO~2~ sparge (solid line, squares) and without (dotted line, triangles). Sparging with CO~2~ increased biomass production and allowed increased glucose catabolism.Fig. 6

Our results indicate that in the presence of CO~2~, glucose is catabolised at a slower rate to all three major fermentation products and propionate is favoured over acetate. Such a phenotype is identical to that observed when acid stress is applied by reduction in the external pH ([@bib11]). Likewise, CO~2~ can also trigger acid stress ([@bib4], [@bib39]). Despite the fact that near equal amounts of dissolved CO~2~ and carbonate will be present in the fermenter at pH 6.4, a lack of homologues for bacterial carbonate transporters ([@bib30]) and a higher permeability of dissolved CO~2~ ([@bib16]) leads to cytoplasmic acidification.

Metabolic modelling suggests CO~2~ fixation does not directly promote propionate production and does not enhance energy. Fixation occurred only when flux was constrained through the native PPi-PEPCK ([@bib38]), resulting in an energetic penalty and the equimolar production of succinate, consistent with experimental results ([@bib44], [@bib45]). Further conversion to propionate was only viable in the presence of MMD.

The above results lead us to propose a novel mechanism by which CO~2~ can modify *Propionibacterium* metabolism by overcoming thermodynamic limitations. Assuming a mechanism of transport by diffusion, intracellular propionate is expected to increase across the course of the fermentation as extracellular propionate accumulates and the pH gradient diminishes. In addition to decoupling the proton gradient, accumulating propionate is expected to inhibit metabolism kinetically and may eventually form a thermodynamic barrier. This is particularly possible given the Wood-Werkman cycle is entirely reversible ([@bib34]). The fixation of CO~2~ through the PPi-dependent PEPCK would help build the concentrations of key metabolic intermediates in the Wood-Werkman cycle allowing further flux through the pathway and resulting in the increased consumption of substrate observed.

4.4. Influence of the linear pathway for propionate production on the metabolism of *P. freudenreichii* subsp. *shermanii* {#s0120}
--------------------------------------------------------------------------------------------------------------------------

The linear pathway for propionate production is a promising, energetically beneficial route to propionate identified by studying the pan *Propionibacterium* genome (manuscript in preparation). The strategy consists of over-expression of the ATP-dependent PEPCK, which improves the growth rate and succinate yield in *E. coli* strains lacking the PEP carboxylase ([@bib19]) along with the sodium-pumping MMD, the key energy-yielding step in the fermentation of succinate to propionate for organisms such as *Propionigenium modestum* ([@bib37]).

Expression of the linear propionate pathway resulted in a continuation of the exponential growth phase at a reduced growth rate. Both glucose catabolism and the production of all fermentation products are stimulated compared to CO~2~-sparged Pf-EMP. This appears to come at a trade-off for propionate specificity; compared to CO~2~-sparged Pf-EMP the propionate to acetate yield is lower in the transition and stationary phases. Increased succinate production suggests that the ATP-PEPCK operates in the direction of oxaloacetate synthesis, but suggests MMD activity may be limiting. While an increased growth rate was expected, it is possible that additional energy was captured as polyphosphate and utilised to fuel further growth at the end of the exponential growth phase instead ([@bib9]). A more pronounced phenotype is expected if more PEP is available, such as during the catabolism of disaccharides.

5. Conclusion {#s0125}
=============

In this work, we proposed several genetic engineering strategies for the improvement of propionic acid production in propionibacteria using genome-scale modelling. Two fundamental strategies were identified by exploring pathways encoded within the pan-genome of propionibacteria that lead to the generation of reduced cofactors or enhanced energy production. The first two enzymes of the oxidative branch of the PPP were over-expressed, resulting in a 4-fold increase in the propionate to acetate ratio during the exponential growth phase and demonstrating the ability for NADPH to couple to the Wood-Werkman cycle. Furthermore, our results from the over-expression of the ATP-dependent PEPCK and the sodium-pumping MMD suggest that MMD activity may be limiting and that the ATP-PEPCK operates in the direction of oxaloacetate and ATP synthesis in *Propionibacterium.* The growth rate of this mutant was higher than that of the empty plasmid strain as predicted by the model. Sparging CO~2~ into the fermenter was surprisingly beneficial for cell growth and propionate production. These findings suggest a CO~2~ sparge may be a cheap, novel method to promote the production of propionate, offering new opportunities to influence propionate production in efficient native producers.

Appendix A. Supplementary material {#s0135}
==================================
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[^3]: ATP maximisation represents the presumed objective function of metabolism, consistent with wild-type flux distributions. Strategies that enhance the minimum propionate production at maximisation of ATP are growth coupling, while strategies that additionally enhance maximum ATP production likely improve acid tolerance. Non-growth coupled strategies cannot rely on evolution and will require additional interventions to achieve the desired phenotype.

[^4]: Optimal over-expression of the pathways to achieve the maximum theoretical yield of propionate at the highest ATP yield possible. A higher energy here makes the strategy more favourable.

[^5]: The wild-type and acetate kinase knock-out pathways are presumed to utilise the pentose phosphate pathway when maximising for propionate production.

[^6]: \*Values corresponding to exponential growth phase (28--43 h), carbon balance 111% Pf-EMP, 90% Pf-ZOP, and to stationary phase (60--120 h), carbon balance 93% Pf-EMP, 88% Pf-ZOP.

[^7]: \*Values corresponding to exponential growth phase (24--50 h), carbon balance 130% Pf-EMP, 114% Pf-PAM, and to stationary phase (64--137 h), carbon balance 89% Pf-EMP, 91% Pf-PAM.

[^8]: \*Values corresponding to transitional growth phase (50--64 h), carbon balance 113% Pf-EMP, 119% Pf-PAM.
